Investors Professionals Patients
Home
About Sicel Reimbursement Products Partnerships Contact Us
 
 
 



Sicel Technologies is pioneering a revolution in cancer therapy.

We are developing telemetric systems that use miniature implantable wireless sensor technologies to continuously provide real time feedback about biological and physiological changes in cell and organ systems.

Clinicians may be able to use this powerful information about tumor cells to impact the treatment or the timing of treatment to target the tumors more effectively and, ultimately, to develop individual treatment protocols based more closely on the patient's own biological information and response to therapy.

In 2006, Sicel Technologies, introduced DVS, the first and only implantable radiation dosimeter to verify radiation dose delivered to the tumor site. In conjunction with planning and delivery tools used in radiation therapy, DVS provides information to deliver more consistent daily dose and optimized treatment plans to each patient.

A bit of background.
Located in North Carolina's world-renowned Research Triangle Park, Sicel was founded by Dr. Charles Scarantino. As an oncologist, Dr. Scarantino perceived a need for a diagnostic tool to provide a reliable and stable method to continuously provide feedback to the physician about the changes within tumors of patients undergoing cancer therapy. The concept of a continuous feedback system was extended to include a number of physiological and kinetic parameters believed to be associated with malignant growth as well as other abnormal physiological changes.